A dual role of the nf-kappa b pathway in neonatal hypoxic-ischemic brain damage

Stroke

Volumn 39, Issue 9, 2008, Pages 2578-2586

  Nijboer, Cora H ^a   Heijnen, Cobi J ^a   Groenendaal, Floris ^a   May, Michael J ^b   Van Bel, Frank ^a   Kavelaars, Annemieke ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Inflammation; Ischemia; Neonatal; Neuroprotection; Nuclear factor kB

Indexed keywords

CYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA B INHIBITOR TAT NBD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; PUMA PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULE; NERVE CELL CULTURE; NEUROPROTECTION; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION; ANIMAL; BRAIN; BRAIN INFARCTION; CELL CULTURE; CELL NUCLEUS; CELL PROTECTION; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PUMA; SPRAGUE DAWLEY RAT; TIME; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CEREBRAL INFARCTION; CYTOKINES; CYTOPROTECTION; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; PUMA; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 52449126395     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.516401     Document Type: Article

References (25)

1. Perlman JM. Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin Ther. 2006;28:1353-1365.
2. Nichols TC. NF-kappaB and reperfusion injury. Drug News Perspect. 2004;17:99-104.
3. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18: 2195-2224.
4. Bouchier-Hayes L, Lartigue L, Newmeyer DD. Mitochondria: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2640-2647.
5. Kuwana T, Newmeyer DD. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol. 2003;15:691-699.
6. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol. 2002;35:28-40.
7. Burstein E, Duckett CS. Dying for NF-kappaB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol. 2003;15:732-737.
8. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF-kappaB is the answer-role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 2003;22:8961-8982.
9. Chang YC, Huang CC. Perinatal brain injury and regulation of transcription. Curr Opin Neurol. 2006;19:141-147.
10. Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107:247-254.
11. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A (2008) Strong neuroprotection by inhibition of NF-κB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke, in press.
12. May MJ, D'Acquisto F, Madje LA, Glockner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science. 2000; 289:1550-1554.
13. van den Tweel ER, Kavelaars A, Lombardi MS, Groenendaal F, May M, Heijnen CJ, van Bel F. Selective inhibition of nuclear factor-kappaB activation after hypoxia/ischemia in neonatal rats is not neuroprotective. Pediatr Res. 2006;59:232-236.
14. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ. Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab. 2007;27:282-292.
15. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 2006;1088:167-175.
16. Herrmann O, Baumann B, de Lorenzi R, Muhammad S, Zhang W, Kleesiek J, Malfertheiner M, Kohrmann M, Potrovita I, Maegele I, Beyer C, Burke JR, Hasan MT, Bujard H, Wirth T, Pasparakis M, Schwaninger M. IKK mediates ischemia-induced neuronal death. Nat Med. 2005;11: 1322-1329.
17. Schwaninger M, Inta I, Herrmann O. NF-kappaB signalling in cerebral ischemia. Biochem Soc Trans. 2006;34:1291-1294.
18. Northington FJ, Graham EM, Martin LJ. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited. Brain Res Brain Res Rev. 2005;50:244-257.
19. Hellin AC, Calmant P, Gielen J, Bours V, Merville MP. Nuclear factor -kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug. Oncogene. 1998;16:1187-1195.
20. Culmsee C, Mattson MP. p53 in neuronal apoptosis. Biochem Biophys Res Commun. 2005;331:761-777.
21. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci. 2002;22:5910-5919.
22. Lin S, Cox HJ, Rhodes PG, Cai Z. Neuroprotection of alpha-phenyl-n-tert- butyl-nitrone on the neonatal white matter is associated with anti-inflammation. Neurosci Lett. 2006;405:52-56.
23. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol. 2003;140:471-476.
24. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M. Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:30-40.
25. Cowan F, Rutherford M, Groenendaal F, Eken P, Mercuri E, Bydder GM, Meiners LC, Dubowitz LM, de Vries LS. Origin and timing of brain lesions in term infants with neonatal encephalopathy. Lancet. 2003;361: 736-742.